Clinical Trials Logo

Filter by:
NCT ID: NCT02012569 Completed - Burns Clinical Trials

Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting

EHTIC
Start date: November 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the haemostatic efficacy of TT-173, reducing the bleeding time in the donor site of skin grafting.

NCT ID: NCT02012387 Completed - Clinical trials for Cholinergic Urticaria

Efficacy Study of Omalizumab in Cholinergic Urticaria

CUN-OMAL-UCOL
Start date: January 2014
Phase: Phase 2
Study type: Interventional

To demonstrate the efficacy and safety of Omalizumab in a new indication, that is cholinergic urticaria.

NCT ID: NCT02012088 Completed - Lymphoma Clinical Trials

Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb

Start date: October 11, 2013
Phase: Phase 2
Study type: Interventional

The Phase II study proposed here assesses the hypothesis that replacing doxorubicin by Myocet® in the R-CHOP regimen would yield comparable antitumour efficacy with a lower cardiotoxicity for first-line treatment in elderly patients with non-localised DLBCL/Follicular lymphoma grade IIIb

NCT ID: NCT02011945 Completed - Clinical trials for Chronic Myeloid Leukemia

A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia

Start date: February 7, 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find a dose of Nivolumab that can be safely added to Dasatinib in patients with Chronic Myeloid Leukemia.

NCT ID: NCT02011477 Completed - Hyperalgesia Clinical Trials

Hypoalgesic Effects Neural Mobilization Techniques

NM
Start date: March 2013
Phase: Phase 0
Study type: Interventional

The purpose of this study was to evaluate the immediate mechanical hypoalgesic effect of neural mobilization in asymptomatic subjects. We also compared neural gliding versus neural stretching to see which produced greater hypoalgesic effects in asymptomatic subjects.

NCT ID: NCT02010931 Completed - Clinical trials for Acute Lymphoblastic Leukemia

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Start date: September 2013
Phase:
Study type: Observational

A retrospective analysis of historical data looking at relapse free survival and overall survival rates in adult philadelphia negative B-pre-cursor acute lymphoblastic leukemia patients.

NCT ID: NCT02010255 Completed - Clinical trials for Chronic HCV Infection

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Start date: January 2014
Phase: Phase 2
Study type: Interventional

This study will evaluate ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) plus ribavirin (RBV) in participants with advanced liver disease or posttransplant and chronic genotype 1 or 4 hepatitis C virus (HCV) infection. - Cohort A: decompensated cirrhosis (advanced liver disease), no prior liver transplant; - Cohort B: post-liver transplant, with or without cirrhosis; - Group assignment within cohorts is based on severity of liver impairment at screening (Child-Pugh-Turcotte (CPT) score for participants with cirrhosis; fibrosis; or presence of disease for fibrosing cholestatic hepatitis (FCH) groups) - Randomization is 1:1 within groups to 12 or 24 weeks of LDV/SOF+RBV treatment.

NCT ID: NCT02009956 Completed - Clinical trials for Coronary Artery Disease

EXCELLA Post-Approval Study

Start date: February 26, 2014
Phase: N/A
Study type: Interventional

To evaluate long-term safety and performance of the DESyne Novolimus Eluting Coronary Stent System and the DESyne BD Novolimus Eluting Coronary Stent System

NCT ID: NCT02009878 Completed - Clinical trials for Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Start date: November 2013
Phase: Phase 1/Phase 2
Study type: Interventional

This is a study to evaluate how the body handles and metabolizes (PK) the various doses of the drug Tolvaptan, and what the effect (PD) of the various doses of Tolvaptan are on the content of "salt" in blood and urine

NCT ID: NCT02009631 Completed - Breast Cancer Clinical Trials

A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

Start date: November 2013
Phase: Phase 1
Study type: Interventional

This is a randomized Phase 1 study to evaluate the effects of Veliparib on cardiac repolarization in patients with solid tumors who's cancer has recurred or is no longer responding to current treatment.